CHINA BOTULINUM TOXIN MARKET FORECAST 2021-2026

The China botulinum toxin market is evaluated to project a CAGR of 7.50% over the forecast years. The market growth of the country is primarily facilitated by factors such as the transitioning consumption habits resulting in increased expenditure on medical beauty, economic developments, and the rising incidence of migraines. The base year considered for the market study is 2020, and the estimated period is from 2021 to 2026.

china-botulinum-toxin-market

The medical use of botulinum toxin type A in China entails the treatment of adult blepharospasm and prosopospasm, as well as several strabismuses, including concomitant strabismus, acute paralytic strabismus, and others. The incidence of facial neuropathy is continually increasing in the country, in addition to several individuals experiencing prosopospasm when fatigued or over-stressed. With a global yearly prevalence of nearly 0.003%, facial neuropathy is more prevalent in women than in men, and in the elderly and middle-aged populace, than other age groups.

On the other hand, most botulinum toxin type A users include women pursuing fewer wrinkles or a thin face. However, as the market demand continues to augment, several beauty salons and medical institutions across China have started using botulinum toxin type A smuggled from Germany, France, and South Korea for their customers. Although the Chinese government only approves the sale of Hengli and Botox, contraband botulinum toxin type A products are easily available in the nation. Hence, these factors are set to influence China’s market growth over the forecasting period.

Medytox, a global biopharmaceutical company, continues to establish efforts for building a better future with incessant research and development. Intending to expand to the United States and Europe, it plans to exceed 10% of the global market share, incorporated with the launch of new botulinum toxin product types, currently under development. The company is headquartered in Korea, Republic of (South).

TABLE OF CONTENTS
  1. RESEARCH SCOPE & METHODOLOGY
    1. STUDY OBJECTIVES
    2. SCOPE OF STUDY
    3. METHODOLOGY
    4. ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    1. MARKET SIZE & ESTIMATES
    2. COUNTRY SNAPSHOT
    3. COUNTRY ANALYSIS
    4. KEY GROWTH ENABLERS
    5. KEY CHALLENGES
  3. KEY ANALYTICS
    1. IMPACT OF COVID-19 ON CHINA BOTULINUM TOXIN MARKET
    2. KEY MARKET TRENDS
    3. PORTER’S FIVE FORCES ANALYSIS
      1. BUYER POWER
      2. SUPPLIER POWER
      3. SUBSTITUTION
      4. NEW ENTRANTS
      5. INDUSTRY RIVALRY
    4. OPPORTUNITY MATRIX
  4. MARKET BY TYPE
    1. TYPE A
    2. TYPE B
  5. MARKET BY APPLICATION
    1. COSMETIC APPLICATIONS
      1. GLABELLAR LINES
      2. LATERAL CANTHAL LINES (CROW’S FEET)
      3. FOREHEAD LINES
      4. OTHER COSMETIC APPLICATIONS
    2. NON-COSMETIC APPLICATIONS
      1. DYSTONIA
      2. CHRONIC MIGRAINE
      3. OPHTHALMOLOGIC DISORDERS
      4. OTHER NON-COSMETIC APPLICATIONS
  6. MARKET BY END-USER
    1. HOSPITALS
    2. CLINICS AND OTHERS
  7. COMPETITIVE LANDSCAPE
    1. KEY STRATEGIC DEVELOPMENTS
      1. PRODUCT LAUNCHES & DEVELOPMENTS
    2. COMPANY PROFILES
      1. ABBVIE INC (ALLERGAN PLC)
      2. HUGEL INC
      3. IPSEN PHARM
      4. MERZ PHARMA
LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – CHINA BOTULINUM TOXIN

TABLE 2: CHINA BOTULINUM TOXIN MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 3: CHINA BOTULINUM TOXIN MARKET, BY TYPE, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 4: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 5: CHINA BOTULINUM TOXIN MARKET, BY APPLICATION, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 6: CHINA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 7: CHINA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 8: CHINA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 9: CHINA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 10: CHINA BOTULINUM TOXIN MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

TABLE 11: CHINA BOTULINUM TOXIN MARKET, BY END-USER, FORECAST YEARS, 2021-2026 (IN $ MILLION)

TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

FIGURE 3: OPPORTUNITY MATRIX

FIGURE 4: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY TYPE, IN 2020

FIGURE 5: CHINA BOTULINUM TOXIN MARKET, BY TYPE A, 2021-2026 (IN $ MILLION)

FIGURE 6: CHINA BOTULINUM TOXIN MARKET, BY TYPE B, 2021-2026 (IN $ MILLION)

FIGURE 7: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2020

FIGURE 8: CHINA BOTULINUM TOXIN MARKET, BY COSMETIC APPLICATIONS, 2021-2026 (IN $ MILLION)

FIGURE 9: CHINA BOTULINUM TOXIN MARKET, BY GLABELLAR LINES, 2021-2026 (IN $ MILLION)

FIGURE 10: CHINA BOTULINUM TOXIN MARKET, BY LATERAL CANTHAL LINES (CROW’S FEET), 2021-2026 (IN $ MILLION)

FIGURE 11: CHINA BOTULINUM TOXIN MARKET, BY FOREHEAD LINES, 2021-2026 (IN $ MILLION)

FIGURE 12: CHINA BOTULINUM TOXIN MARKET, BY OTHER COSMETIC APPLICATIONS, 2021-2026 (IN $ MILLION)

FIGURE 13: CHINA BOTULINUM TOXIN MARKET, BY NON-COSMETIC APPLICATIONS, 2021-2026 (IN $ MILLION)

FIGURE 14: CHINA BOTULINUM TOXIN MARKET, BY DYSTONIA, 2021-2026 (IN $ MILLION)

FIGURE 15: CHINA BOTULINUM TOXIN MARKET, BY CHRONIC MIGRAINE, 2021-2026 (IN $ MILLION)

FIGURE 16: CHINA BOTULINUM TOXIN MARKET, BY OPHTHALMOLOGIC DISORDERS, 2021-2026 (IN $ MILLION)

FIGURE 17: CHINA BOTULINUM TOXIN MARKET, BY OTHER NON-COSMETIC APPLICATIONS, 2021-2026 (IN $ MILLION)

FIGURE 18: CHINA BOTULINUM TOXIN MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020

FIGURE 19: CHINA BOTULINUM TOXIN MARKET, BY HOSPITALS, 2021-2026 (IN $ MILLION)

FIGURE 20: CHINA BOTULINUM TOXIN MARKET, BY CLINICS AND OTHERS, 2021-2026 (IN $ MILLION)

Request For A Free Sample